Insider trade

Director sold ~$243K of EXEL shares in the open market

Traded Nov 11, 2025 · Filed Nov 14, 2025

Why it stands out

A Exelixis director sold $243K of Exelixis shares. The filing references vesting of compensation awards.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$100K–$500KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$243,102

Shares × reported transaction price

Timing vs results

7 days after results of Nov 4, 2025, 62 days before results of Jan 12, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+2.1%	−1.9%	+4.0%
30 days	−0.7%	+1.3%	−2.0%
90 days	+2.5%	+1.4%	+1.1%
180 days	+23.1%	+10.5%	+12.7%

Past results only. Not a forecast.

Includes 21,380 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Filed 10mo ago

Traded Dec 3, 2025 · filed 2 days later

Compensation award — excluded from discretionary-purchase analysis.

Filed 11mo ago

Bought

Traded Nov 25, 2025 · filed 1 day later

A Exelixis director paid $1.19M out of pocket for Exelixis shares.

Automatic saleFiled 11mo ago